FDA trims use of contentious Alzheimer’s drug amid backlash

By
dementianews
-
FDA trims use of contentious Alzheimer's drug amid backlash
This image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. On Thursday, July 8, 2021, U.S. health regulators approved new prescribing instructions for the controversial Alzheimer’s drug that are likely to limit use of the expensive therapy, which has faced an intense public backlash. Credit: Biogen via AP, File

A month after approving a controversial new Alzheimer’s drug, U.S. health regulators on Thursday signed off on new prescribing instructions that are likely to limit its use.

The Food and Drug Administration said the change is intended to address confusion among physicians and patients about who should get the…

Read more…

RELATED ARTICLESMORE FROM AUTHOR